cigna and glp 1 meds Health insurer will stop covering GLP-1 weight loss drugs in its employee health plan Cigna is making GLP-1 coverage

Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A

Storage position matters more than many patients realize

A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes

In exploring the treatment of obesity and its associated complications, such as Type 2 diabetes and cardiovascular disease, a prominent and popular target is the Glucagon-Like Peptide-1 Receptor (GLP-1R)

It seems very unlikely that the glucagon released by GIPR activation counteracts the incretin effect, as this would result in a counterproductive postprandial response that would not promote metabolic homeostasis in the individual

Vegan, gluten-free, non-GMO